Johannes Zuber

52PUBLICATIONS

352CO-AUTHORS

Nanoscale characterisationPredictive and prognostic markersIndustrial molecular engineering of nucleic acids and proteinsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (52)

Sort by Publication Date:

|Jun 25, 2026

Cellular assembly and functional resilience of the mammalian RNA exosome.

|Mar 06, 2026

Functional genomic screens uncover FERMT2 as a critical regulator of YAP/TAZ-driven tumorigenicity.

Arianna Chiesa, Vittoria Poli, Ottavio Croci

|Feb 04, 2026

A multivalent adaptor mechanism drives the nuclear import of proteasomes.

Hanna L Brunner, Robert W Kalis, Lorenz Grundmann

|Jan 28, 2026

In vivo CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differentiation.

Lesly Calderón, Markus Schäfer, Marina Rončević

|Dec 26, 2025

Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer.

Cristina Queralt, Cristina Moreta-Moraleda, Marta Costa

|Nov 26, 2025

Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Ulrike Höckendorf, Sayantanee Dutta, Arnold Kloos

Pageof 9

Frequent Collaborators

Tobias Neumann

Julian Jude

Robert W Kalis

Florian Grebien

Peter Valent

Johannes Schmöllerl

Anna C Obenauf

Matthias Hinterndorfer

4 joint publications

Stefan L Ameres

4 joint publications

Christoph Bock

Frequent Collaborators

Tobias Neumann

Julian Jude

Robert W Kalis

Florian Grebien